Reihnér, E <br/><br/>
Influence of pravastatin, a specific inhibitor of HMG-CoA reductase, on hepatic metabolism of cholesterol.  [electronic resource] 

 -  The New England journal of medicine  Jul 1990 
 - 224-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-4793 
<br/><br/><label>Standard No.: </label>10.1056/NEJM199007263230403  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anticholesteremic Agents--administration & dosage<br/>Cholelithiasis--drug therapy<br/>Cholesterol--biosynthesis<br/>Cholesterol 7-alpha-Hydroxylase--analysis<br/>Cholesterol, LDL--blood<br/>Female<br/>Heptanoic Acids--administration & dosage<br/>Humans<br/>Hydroxymethylglutaryl CoA Reductases--analysis<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors<br/>Liver--drug effects<br/>Male<br/>Microsomes, Liver--enzymology<br/>Middle Aged<br/>Naphthalenes--administration & dosage<br/>Pravastatin<br/>Receptors, LDL--metabolism<br/>Sterol O-Acyltransferase--analysis